Due to the rapid development of obesity and related metabolic diseases in the world, it is particularly important to explore the ability of novel materials in regulating obesity. In this study, C57BL/6J obese mice were used as objects, and 16S rRNA gene sequencing and lipidomics techniques were used to explore the regulatory effect and mechanism of the P. brevitarsis ethanol extract (50%, v/v) against obesity. Our results showed that P. brevitarsis extract could significantly reduce the body weight, triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and pro-inflammatory cytokines (TNF-α, IFN-γ, and IL-6) levels of HFD-fed mice. Moreover, the P. brevitarsis extract changed the composition and relative abundance of its gut microbiota, especially increasing Akkermansia muciniphila. Meanwhile, the content of short-chain fatty acids (SCFAs) was increased, especially acetic acid and butyric acid, which leads to a decrease in the synthesis and accumulation of lipids in the liver. Furthermore, the P. brevitarsis extract also induced the difference in lipid synthesis in the liver by down-regulating the mRNA levels of SREPB-1C, FAS, and ACC. Therefore, this research provided preliminary work and reference for the development of P. brevitarsis as a functional food for anti-obesity.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: